SE0003476D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- SE0003476D0 SE0003476D0 SE0003476A SE0003476A SE0003476D0 SE 0003476 D0 SE0003476 D0 SE 0003476D0 SE 0003476 A SE0003476 A SE 0003476A SE 0003476 A SE0003476 A SE 0003476A SE 0003476 D0 SE0003476 D0 SE 0003476D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- compounds
- diseases
- general formula
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/22—Eight-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0003476A SE0003476D0 (sv) | 2000-09-28 | 2000-09-28 | Compounds |
EP01970480A EP1324992B1 (en) | 2000-09-28 | 2001-09-27 | Cyclized benzamide neurokinin antagonists for use in therapy |
AT01970480T ATE369348T1 (de) | 2000-09-28 | 2001-09-27 | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie |
PCT/SE2001/002100 WO2002026724A1 (en) | 2000-09-28 | 2001-09-27 | Cyclized benzamide neurokinin antagonists for use in therapy |
AU2001290480A AU2001290480A1 (en) | 2000-09-28 | 2001-09-27 | Cyclized benzamide neurokinin antagonists for use in therapy |
ES01970480T ES2288988T3 (es) | 2000-09-28 | 2001-09-27 | Antagonistas de benzamida-neurokinina ciclados para su uso en terapia. |
US10/381,755 US6924277B2 (en) | 2000-09-28 | 2001-09-27 | Cyclized benzamide neurokinin antagonists for use in therapy |
DE60129829T DE60129829T2 (de) | 2000-09-28 | 2001-09-27 | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in der therapie |
JP2002531108A JP2004509954A (ja) | 2000-09-28 | 2001-09-27 | 治療に用いるための環化したベンズアミドニューロキニンアンタゴニスト |
US11/115,572 US20050192318A1 (en) | 2000-09-28 | 2005-04-27 | Compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0003476A SE0003476D0 (sv) | 2000-09-28 | 2000-09-28 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0003476D0 true SE0003476D0 (sv) | 2000-09-28 |
Family
ID=20281199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0003476A SE0003476D0 (sv) | 2000-09-28 | 2000-09-28 | Compounds |
Country Status (9)
Country | Link |
---|---|
US (2) | US6924277B2 (sv) |
EP (1) | EP1324992B1 (sv) |
JP (1) | JP2004509954A (sv) |
AT (1) | ATE369348T1 (sv) |
AU (1) | AU2001290480A1 (sv) |
DE (1) | DE60129829T2 (sv) |
ES (1) | ES2288988T3 (sv) |
SE (1) | SE0003476D0 (sv) |
WO (1) | WO2002026724A1 (sv) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006013205A1 (en) * | 2004-08-04 | 2006-02-09 | Solvay Pharmaceuticals B.V. | Neurokinin-1 receptor antagonists for the treatment of conditions responsive to testosterone elevation |
US20060030556A1 (en) * | 2004-08-04 | 2006-02-09 | Solvay Pharmaceuticals B.V. | Neurokinin-1 receptor antagonists for the treatment of conditions responsive to testosterone elevation, including testosterone deficiency |
DE102004038134B4 (de) | 2004-08-05 | 2013-07-25 | Johann Wolfgang Goethe-Universität Frankfurt am Main | Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung |
US20060030600A1 (en) * | 2004-08-06 | 2006-02-09 | Patrick Schnider | Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia |
WO2007076875A2 (en) * | 2006-01-06 | 2007-07-12 | Aarhus Universitet | Compounds acting on the serotonin transporter |
EP2117538A1 (en) | 2007-01-24 | 2009-11-18 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-) |
WO2012061754A2 (en) * | 2010-11-05 | 2012-05-10 | The Broad Institute, Inc. | Compounds and methods for treating autoimmune diseases |
EP2691391A4 (en) | 2011-03-29 | 2014-09-10 | Broad Inst Inc | COMPOUNDS AND METHODS FOR THE TREATMENT OF DISEASES RELATED TO ISOCITRATE DEHYDROGENASE |
WO2013004766A1 (en) | 2011-07-04 | 2013-01-10 | Ferrari Giulio | Nk-1 receptor antagonists for treating corneal neovascularisation |
TW201427947A (zh) | 2012-10-12 | 2014-07-16 | Lundbeck & Co As H | 環狀胺 |
TWI598325B (zh) * | 2012-10-12 | 2017-09-11 | H 朗德貝克公司 | 苯甲醯胺類 |
US20210015834A1 (en) | 2018-02-26 | 2021-01-21 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
RU2697414C1 (ru) | 2018-05-11 | 2019-08-14 | Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс" | Новый антагонист тахикининовых рецепторов и его применение |
EP4117673A1 (en) | 2020-03-11 | 2023-01-18 | Ospedale San Raffaele S.r.l. | Treatment of stem cell deficiency |
CA3234312A1 (en) * | 2021-09-30 | 2023-04-06 | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | Four-membered fused cyclic compound and preparation method and use thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2935541B2 (ja) * | 1990-06-28 | 1999-08-16 | サントリー株式会社 | 縮合複素環化合物 |
US5525600A (en) * | 1994-11-28 | 1996-06-11 | American Home Products Corporation | (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides |
GB9505084D0 (en) | 1995-03-14 | 1995-05-03 | Pfizer Ltd | Benzamide derivative |
US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
US5998439A (en) * | 1996-02-21 | 1999-12-07 | Hoescht Marion Roussel, Inc. | Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
US5789422A (en) | 1996-10-28 | 1998-08-04 | Schering Corporation | Substituted arylalkylamines as neurokinin antagonists |
GB9922521D0 (en) * | 1998-10-07 | 1999-11-24 | Zeneca Ltd | Compounds |
FR2792835B3 (fr) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression |
WO2001077089A1 (en) * | 2000-04-06 | 2001-10-18 | Astrazeneca Ab | New neurokinin antagonists for use as medicaments |
-
2000
- 2000-09-28 SE SE0003476A patent/SE0003476D0/sv unknown
-
2001
- 2001-09-27 DE DE60129829T patent/DE60129829T2/de not_active Expired - Fee Related
- 2001-09-27 AU AU2001290480A patent/AU2001290480A1/en not_active Abandoned
- 2001-09-27 US US10/381,755 patent/US6924277B2/en not_active Expired - Fee Related
- 2001-09-27 JP JP2002531108A patent/JP2004509954A/ja active Pending
- 2001-09-27 AT AT01970480T patent/ATE369348T1/de not_active IP Right Cessation
- 2001-09-27 WO PCT/SE2001/002100 patent/WO2002026724A1/en active IP Right Grant
- 2001-09-27 ES ES01970480T patent/ES2288988T3/es not_active Expired - Lifetime
- 2001-09-27 EP EP01970480A patent/EP1324992B1/en not_active Expired - Lifetime
-
2005
- 2005-04-27 US US11/115,572 patent/US20050192318A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1324992B1 (en) | 2007-08-08 |
US20050192318A1 (en) | 2005-09-01 |
DE60129829T2 (de) | 2008-04-30 |
AU2001290480A1 (en) | 2002-04-08 |
DE60129829D1 (de) | 2007-09-20 |
EP1324992A1 (en) | 2003-07-09 |
US6924277B2 (en) | 2005-08-02 |
JP2004509954A (ja) | 2004-04-02 |
ATE369348T1 (de) | 2007-08-15 |
US20040029850A1 (en) | 2004-02-12 |
WO2002026724A1 (en) | 2002-04-04 |
ES2288988T3 (es) | 2008-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6658A (is) | Ný efnasambönd | |
IS6520A (is) | Ný efnasambönd | |
DK1200418T3 (da) | Nematodicide trifluorbutener | |
SE0104251D0 (sv) | Novel compounds | |
ATE316083T1 (de) | Adamantanderivate | |
SE0302139D0 (sv) | Novel compounds | |
ATE386725T1 (de) | Heterocyclylverbindungen | |
SE0003476D0 (sv) | Compounds | |
YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
SE0104250D0 (sv) | Heterocyclic compounds | |
NO20020282L (no) | Nytt difenyl-piperidinderivat | |
DE60021381D1 (de) | Chinonverbindungen zur behandlung von krankheiten | |
AU1182702A (en) | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same | |
SE0101038D0 (sv) | Novel compounds | |
ATE311389T1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
DK1532131T3 (da) | Motilid-forbindelser | |
SE0303280D0 (sv) | Novel compounds | |
SE0302755D0 (sv) | Novel compounds | |
DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
ID25478A (id) | Agonis 5-ht1f | |
SE0004827D0 (sv) | Therapeutic compounds | |
ATE293591T1 (de) | Neue n-(2-phenyl-3-aminopropyl)naphtamide | |
UY27587A1 (es) | Heterociclos terapéuticos | |
CY1110139T1 (el) | Γλυκοπεπτιδικα αντιβιοτικα | |
ATE382363T1 (de) | Pharmazeutische zusammensetzung enthaltend bulbophyllum |